Literature DB >> 12515830

Modulation of transforming growth factor-beta (TGF-beta) signaling by endogenous sphingolipid mediators.

Madoka Sato1, Margaret Markiewicz, Masoyoshi Yamanaka, Alicja Bielawska, Cungui Mao, Lina M Obeid, Yusuf A Hannun, Maria Trojanowska.   

Abstract

Transforming growth factor-beta (TGF-beta) is a multifunctional growth factor that plays a critical role in tissue repair and fibrosis. Sphingolipid signaling has been shown to regulate a variety of cellular processes and has been implicated in collagen gene regulation. The present study was undertaken to determine whether endogenous sphingolipids are involved in the TGF-beta signaling pathway. TGF-beta treatment induced endogenous ceramide levels in a time-dependent manner within 5-15 min of cell stimulation. Using human fibroblasts transfected with a alpha2(I) collagen promoter/reporter gene construct (COL1A2), C(6)-ceramide (10 microm) exerted a stimulatory effect on basal and TGF-beta-induced activity of this promoter. Next, to define the effects of endogenous sphingolipids on TGF-beta signaling we employed ectopic expression of enzymes involved in sphingolipid metabolism. Sphingosine 1-phosphate phosphatase (YSR2) stimulated basal COL1A2 promoter activity and cooperated with TGF-beta in activation of this promoter. Furthermore, overexpression of YSR2 resulted in the pronounced increase of COL1A1 and COL1A2 mRNA levels. Conversely, overexpression of sphingosine kinase (SPHK1) inhibited basal and TGF-beta-stimulated COL1A2 promoter activity. These results suggest that endogenous ceramide, but not sphingosine or sphingosine 1-phosphate, is a positive regulator of collagen gene expression. Mechanistically, we demonstrate that Smad3 is a target of YSR2. TGF-beta-induced Smad3 phosphorylation was elevated in the presence of YSR2. Cotransfection of YSR2 with wild-type Smad3, but not with the phosphorylation-deficient mutant of Smad3 (Smad3A), resulted in a dramatic increase of COL1A2 promoter activity. In conclusion, this study demonstrates a direct role for the endogenous sphingolipid mediators in regulating the TGF-beta signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12515830     DOI: 10.1074/jbc.M211529200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Diminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy.

Authors:  Putri A Agustian; Mario Schiffer; Wilfried Gwinner; Irini Schäfer; Katharina Theophile; Friedrich Modde; Clemens L Bockmeyer; Jana Traeder; Ulrich Lehmann; Anika Grosshennig; Hans H Kreipe; Verena Bröcker; Jan U Becker
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice.

Authors:  Tsutomu Matsubara; Naoki Tanaka; Andrew D Patterson; Joo-Youn Cho; Kristopher W Krausz; Frank J Gonzalez
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

Review 3.  Scleroderma, fibroblasts, signaling, and excessive extracellular matrix.

Authors:  Hironobu Ihn
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

4.  Isoflurane via TGF-beta1 release increases caveolae formation and organizes sphingosine kinase signaling in renal proximal tubules.

Authors:  Joseph H Song; Mihwa Kim; Sang Won Park; Sean W C Chen; Stuart M Pitson; H Thomas Lee
Journal:  Am J Physiol Renal Physiol       Date:  2010-01-06

Review 5.  Structure and function of glycosphingolipids and sphingolipids: recollections and future trends.

Authors:  Sen-itiroh Hakomori
Journal:  Biochim Biophys Acta       Date:  2007-09-06

6.  Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-beta-stimulated collagen production by cardiac fibroblasts.

Authors:  Nicole Gellings Lowe; James S Swaney; Kelli M Moreno; Roger A Sabbadini
Journal:  Cardiovasc Res       Date:  2009-02-19       Impact factor: 10.787

7.  Depletion of adipocyte sphingosine kinase 1 leads to cell hypertrophy, impaired lipolysis, and nonalcoholic fatty liver disease.

Authors:  Andrea K Anderson; Johana M Lambert; David J Montefusco; Bao Ngan Tran; Patrick Roddy; William L Holland; L Ashley Cowart
Journal:  J Lipid Res       Date:  2020-07-20       Impact factor: 5.922

8.  Constitutively activated dystrophic muscle fibroblasts show a paradoxical response to TGF-beta and CTGF/CCN2.

Authors:  Valeria Mezzano; Daniel Cabrera; Cecilia Vial; Enrique Brandan
Journal:  J Cell Commun Signal       Date:  2008-04-15       Impact factor: 5.782

Review 9.  Smad3 as a mediator of the fibrotic response.

Authors:  Kathleen C Flanders
Journal:  Int J Exp Pathol       Date:  2004-04       Impact factor: 1.925

10.  Ceramide inhibits CCN2 expression in fibroblasts.

Authors:  Laura Kennedy; Sunil Parapuram; Jill Greenspoon; Andrew Leask
Journal:  J Cell Commun Signal       Date:  2008-07-23       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.